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Background & Aims: Neoplastic B cells of the Helicobac-
ter pylori–related low-grade gastric mucosa-associ-
ated lymphoid tissue (MALT) lymphoma are responsive
to T helper cells and sensitive to withdrawal of H.
pylori–induced T-cell help. Methods: The clonal prog-
eny of T cells from the gastric mucosa of 5 patients with
MALT lymphoma was compared with that of T-cell
clones obtained from 5 H. pylori–infected patients with
chronic gastritis. Results: T-cell clones were assessed
for specificity to H. pylori, cytokine profile, help for
B-cell proliferation, and perforin- or Fas-mediated cyto-
toxic regulation of B-cell growth. Twenty-eight of 165
CD41 gastric clones from MALT lymphoma and 33 of
178 CD41 clones from chronic gastritis recognized H.
pylori antigens. Cytokine production was similar in the
2 series of clones. All MALT lymphoma–derived clones
dose-dependently increased their B-cell help, whereas
clones from chronic gastritis lost helper activity at
T-to-B–cell ratios greater than 1 because of concomi-
tant cytolytic killing of B cells. T-cell clones from MALT
lymphoma had both reduced perforin-mediated cytotox-
icity and poor ability to induce Fas-mediated apopto-
sis. These defects were limited to gastric T cells.
Conclusions: H. pylori–induced T cell–dependent B-cell
activation and deficient cytotoxic control of B-cell
growth may link H. pylori infection, local T-cell re-
sponse, and genesis of low-grade gastric MALT lym-
phoma.
A strong link has been documented between Helicobac-ter pylori infection and development of the gastric
mucosa-associated lymphoid tissue (MALT) lymphoma.1–3
A prerequisite for lymphomagenesis is the development
of secondary inflammatory MALT induced by chronic H.
pylori challenge.3 The tumor cells of low-grade gastric
MALT lymphoma are memory B lymphocytes still
responsive to differentiation signals, such as CD40
costimulation and cytokines produced by antigen-
stimulated T-helper (Th) cells,4 and their growth depends
on stimulation by H. pylori–specific T cells.5,6 In early
phases, this tumor is sensitive to withdrawal of H.
pylori–induced T-cell help, providing an explanation for
both the tumor’s tendency to remain localized to the
primary site and its regression after H. pylori is eradicated
with antibiotics.7,8
Tumor growth may depend on evasion from T cell–
mediated cytotoxicity.9 Two cytotoxic mechanisms are
known10: the first involves local release of perforins and
granzymes by effector T cells and leads to lysis of target
cells,11 and the second induces apoptosis upon the
interaction of Fas ligand expressed by T cells with Fas on
target cells.12 Both mechanisms require antigen-induced
T-cell activation, resulting in degranulation or Fas ligand
up-regulation. T cell–mediated signaling up-regulates
Fas expression and Fas-mediated apoptosis in activated B
cells.
13
The role of this regulatory mechanism is high-
lighted by the notion that both lpr and gld mice, with
mutations in Fas or Fas ligand genes, develop lymphopro-
liferative disorders.14,15
The aims of this study were (1) to provide evidence for
the presence of H. pylori–specific Th cells in the context of
low-grade gastric MALT lymphoma, (2) to define these
cells’ cytokine patterns and mode of delivering help for
B-cell proliferation, and (3) to assess whether gastric T
cells from MALT lymphoma have normal perforin- and/or
Fas-mediated regulatory mechanisms of B-cell prolifera-
tion.
Abbreviations used in this paper: APC, antigen-presenting cell;
CagA, recombinant cytotoxin-associated protein; EBV, Epstein–Barr
virus; EBV-B cells, Epstein–Barr virus–transformed lymphoblastoid B
cells; HSP, recombinant heat shock protein; IL, interleukin; MALT,
mucosa-associated lymphoid tissue; PPD, purified protein deriva-
tive; PMA, phorbol-12-myristate 13-acetate; VacA, recombinant
vacuolating cytotoxin.
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Materials and Methods
Patients
Five untreated patients (2 men and 3 women; mean
age, 68 years; range, 62–76 years) with low-grade B-cell
lymphoma of gastric MALT and 5 patients (2 men and 3
women; mean age, 60 years; range, 56–69 years) with uncom-
plicated chronic gastritis provided informed consent for this
study, which was performed after approval by the local ethical
committee. Multiple biopsy specimens were obtained from the
gastric antrum of patients with chronic gastritis. In patients
with low-grade MALT lymphoma, biopsy specimens were
obtained from perilesional regions. Biopsy specimens were used
for diagnosis (positive urease test, typing of H. pylori strain, and
histology) and culture of tumor-infiltrating T lymphocytes. All
patients with chronic gastritis or MALT lymphoma were
infected with CagA1 VacA1 H. pylori type I strains and were
positive for anti-CagA serum immunoglobulin (Ig) G antibod-
ies, as assessed by Western blot analysis (Helicoblot 2.0;
Genelabs Diagnostic, Geneva, Switzerland).
Generation of H. pylori–Specific
T-Cell Clones
Biopsy specimens were cultured for 7 days in RPMI
1640 medium supplemented with human interleukin (IL)-2
(50 U/mL) (Eurocetus, Milan, Italy) to expand in vivo–
activated T cells.16 Mucosal specimens were disrupted and
single T-cell blasts were cloned under limiting dilution (0.3
cells/well) as reported previously.16,17 Each clone was screened
(in triplicate cultures for each condition) for responsiveness to
H. pylori antigens by measuring [3H]thymidine uptake after 60
hours’ stimulation with medium, H. pylori lysate (aqueous
extract of NCTC11637 strain, 10 µg/mL being optimal),
purified urease,18 recombinant cytotoxin-associated protein
(CagA), recombinant vacuolating cytotoxin (VacA), or recombi-
nant heat shock protein (HSP) (1 µg/mL was optimal) in the
presence of irradiated autologous mononuclear cells as antigen-
presenting cells (APCs), as previously reported in detail.16 A
mitogenic index greater than 10 was considered a positive
result. T-cell clones specific for purified protein derivative
(PPD) of Mycobacterium tuberculosis were derived from peripheral
blood T cells of all patients, as reported.17
Cytokine Profile of H. pylori–Specific
Gastric T-Cell Clones
To assess the cytokine production of H. pylori–specific
Th clones, 106 T-cell blasts of each clone were cocultured in
duplicate cultures for 48 hours in 1 mL of medium with 5 3
105 irradiated autologous peripheral blood mononuclear cells as
APCs and H. pylori lysate (10 µg/mL).16 To induce cytokine
production by gastric T-cell clones with unknown specificity,
T-cell blasts were stimulated for 36 hours with phorbol-12-
myristate 13-acetate (PMA, 10 ng/mL) plus anti-CD3 monoclo-
nal antibody (200 ng/mL), as detailed previously.17 Duplicate
samples of each supernatant were assayed for interferon (IFN)-g
(BioSource International, Camarillo, CA), IL-4, and IL-5 (R&D
Systems, Minneapolis, MN). IL-2, IFN-g, IL-4, IL-5, and
IL-13 (and L32 or GAPDH house-keeping genes, as controls)
messenger RNA expression was determined by a multiprobe
RNAse Protection Assay system (Pharmingen, San Diego, CA),
according to the manufacturer’s protocol.19
Helper Activity of T-Cell Clones for B-Cell
Proliferation
The ability of gastric Th clones to induce B-cell
proliferation was assessed by measuring [3H]thymidine uptake
by peripheral blood B cells (3 3 104) cocultured for 4 days with
different concentrations of irradiated (2000 rad) autologous
clonal T-cell blasts (0.2, 1, and 5 T–B-cell ratio) with or
without H. pylori antigen, as described previously.16 B cell–
enriched suspensions were prepared by a double-step rosetting
with neuraminidase-treated sheep red blood cells, as de-
scribed.20 Peripheral blood B cell–enriched suspensions usually
consisted of 68%–87% B cells, 9%–21% monocytes, and less
than 1% T cells. They are referred to as B cells in this article.
Perforin-Mediated Cytolytic Activity
Perforin-mediated cytolytic activity of T-cell clones
was assessed as reported previously.16 T-cell blasts of H.
pylori–specific clones were incubated at 10-, 5-, and 2.5-to-1
ratios with 51Cr-labeled autologous Epstein–Barr virus (EBV)-
transformed lymphoblastoid B cells (EBV-B cells) preincubated
with H. pylori antigen. After centrifugation to favor T–B-cell
contact, microplates were incubated for 8 hours at 37°C and
0.1 mL of supernatant was removed for measurement of 51Cr
release. Maximum release (MR) was obtained by treating target
cells with 0.1 mL of 1 mol/L HCl. Spontaneous release (SR) was
determined in microcultures without T cells. Specific lysis was
calculated according to the following formula: % Specific
Lysis 5 100(Experimental Release – SR)/(MR – SR). Cultures
in which 51Cr release exceeded the mean SR by more than 5 SD
were considered positive for cytolytic activity. In T-cell clones
with unknown specificity, perforin-mediated cytotoxicity was
tested by a lectin-dependent assay against 51Cr-labeled P815
murine mastocytoma cells at effector-to-target ratios of 10, 5,
and 2.5 to 1, as described previously.16
Fas-Fas Ligand–Mediated Apoptotic Killing
The ability of gastric T-cell clones to induce Fas-Fas
ligand–mediated apoptosis was assessed using Fas1 Jurkat cells
as target.21 T-cell blasts from each clone were cocultured with
51Cr-labeled Jurkat cells at effector-to-target ratios of 10, 5, and
2.5 to 1 for 18 hours in the presence of PMA (10 ng/mL) and
ionomycin (1 mmol/L). Specific lysis was calculated according
to the formula reported above. To block Fas-Fas ligand
interaction, the anti-Fas antagonistic monoclonal antibody M3
(Immunex Corp., Seattle, WA)22 was used at 5 µg/mL final
concentration in 30 minutes’ pretreatment of 51Cr-labeled
Jurkat cells. The anti-Fas or its isotype (IgG1) control was also
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added during the cytolytic assay at 2 µg/mL final concentra-
tion.
Analysis of Fas Ligand Expression by
Gastric T-Cell Lines
T-cell blasts recovered from gastric biopsy specimens of
patients with chronic gastritis and MALT lymphoma were
expanded for 9–12 days in IL-2–conditioned medium to obtain
a number of cells suitable for Fas ligand expression. T-cell
blasts from each line were cultured for 6 hours in medium alone
or in the presence of PMA (10 ng/mL) and ionomycin (1
mmol/L). After they were washed with medium/NaN3, T-cell
blasts were incubated for 30 minutes with the anti-human Fas
ligand biotinylated monoclonal antibody (Clone NOK-1;
Pharmingen) or the appropriate isotype (IgG1) control fol-
lowed by streptavidin-phycoerythrin (Southern Biotechnology
Associates, Birmingham, AL). Flow cytometry was performed
on a Becton Dickinson FACScan flow cytometer, and 5000–
10,000 events were collected per sample.
Results
Antigen Specificity and Cytokine Profile of
Gastric T-Cell Clones
In vivo–activated T cells present in the antral
infiltrates of 5 H. pylori–infected patients with low-grade
MALT lymphoma and patients with H. pylori–induced
uncomplicated chronic gastritis were isolated and cloned.
A total of 165 CD41 and 16 CD81 clones were obtained
from the gastric biopsy specimens of MALT lymphoma;
78 CD41 and 21 CD81T-cell clones were obtained from
chronic gastritis. None of the CD81 clones responded to
H. pylori antigens, whereas 28 CD41 clones from MALT
lymphoma and 33 CD41 clones from chronic gastritis
showed antigen-induced proliferation (Figure 1). In both
types of patients, the proportion of H. pylori–specific
clones ranged between 3% and 20% of the clones
obtained, and each case contributed an almost equal
number of clones. Among the H. pylori–reactive clones
from MALT lymphoma, 25% were specific for urease, 4%
for VacA, and none for CagA or HSP; 71% proliferated
only in response to H. pylori lysate. In chronic gastritis,
the proportion of clones reactive to urease was similar
(27%); a number of clones were specific for CagA, VacA,
or HSP (18%, 9%, and 6%, respectively); and 39%
responded only to H. pylori lysate (Figure 1).
Upon antigen stimulation, 39% of clones from chronic
gastritis produced IFN-g but neither IL-4 nor IL-5 (Th1
profile), whereas 61% secreted both Th1- and Th2-type
cytokines (Th0 profile). The 28 gastric T-cell clones from
MALT lymphoma comprised a smaller proportion of
Th1, more Th0, and a few Th2 clones (Table 1). At
mRNA level, the 2 Th2 clones from MALT lymphoma
confirmed their cytokine profile; among the other clones,
irrespective of their origin, all Th1 expressed mRNA for
IL-2, IFN-g, and IL-13, whereas all Th0 clones also
expressed mRNA for IL-4 and IL-5 with no quantitative
differences in the densitometric analysis of the cytokine
RNA bands (data not shown).
Figure 1. Antigen repertoire of H. pylori–reactive T-cell clones derived
from the gastric mucosa of H. pylori–infected patients with low-grade
MALT B-cell lymphoma (m) or uncomplicated chronic gastritis (s). In
vivo–activated T cells were recovered from biopsy specimens of
gastric mucosa and cloned by limiting dilution. T-cell blasts from each
clone were seeded in triplicate cultures with irradiated autologous
peripheral blood mononuclear cells in the presence of medium alone
or optimal doses of crude H. pylori lysate (10 µg/mL), urease, CagA,
VacA, or HSP (1 µg/mL). After 60 hours, [3H]thymidine uptake was
measured and expressed as mitogenic index.
Table 1. Cytokine Profile of H. pylori–Reactive T-Cell Clones
Derived From the Antral Mucosa of Patients With
MALT Lymphoma or Chronic Gastritis
Patients
No. of
specific
clones/all
CD4 clones
obtained
No. of clones with the
indicated cytokine profile
Th1 Th0 Th2
Low-grade gastric
MALT lymphoma
(n 5 5) 28/165 2 (7%)a,b 24 (86%)c 2 (7%)
Uncomplicated
chronic gastritis
(n 5 5) 33/178 13 (39%)b 20 (61%)c 0 (0%)
aT-cell blasts (106) of each clone were cocultured for 48 hours in 1 mL
of medium with 5 3 105 irradiated autologous APCs and H. pylori
lysate (10 µg/mL). Supernatants were assayed for IFN-g, IL-4, and IL-5
content. T-cell clones producing IFN-g but not IL-4 or IL-5 were coded
as Th1; clones producing IL-4 or IL-5 but not IFN-g were coded as Th2;
clones producing both IFN-g and IL-4 or IL-5 were coded as Th0.
bx2 5 8.5, P , 0.005.
cx2 5 4.75, P , 0.05.
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Antigen-Dependent B-Cell Help by
H. pylori–Specific Th Clones
To assess the ability of H. pylori–specific T-cell
clones to provide antigen-triggered B-cell help, irradi-
ated T-cell blasts of each clone were cocultured at 0.2-, 1-,
and 5-to-1 ratios with autologous peripheral blood B
cells. At a 1-to-1 T-to-B-cell ratio, all antigen-stimulated
H. pylori–specific clones from either chronic gastritis or
MALT lymphoma patients provided substantial help for
B-cell proliferation (mean mitogenic index, 26 and 29;
range, 10–45 and 12–42, respectively; Figure 2). At a
5-to-1 T-to-B-cell ratio, all 28 Th clones from MALT
lymphoma further increased B-cell proliferation, whereas
a remarkable reduction (or extinction) of B-cell prolifera-
tion was observed in the presence of virtually all 33 Th
clones from chronic gastritis (Figure 2).
Lack of Perforin-Mediated Cytotoxicity
to Antigen-Presenting Autologous B Cells
in Gastric T-Cell Clones From MALT
Lymphoma
Because most antigen-activated Th1 and Th0
clones express perforin-mediated cytotoxicity against
antigen-presenting autologous B cells,20 the cytolytic
potential of H. pylori–specific clones obtained from
chronic gastritis or MALT lymphoma was assessed using
antigen-pulsed 51Cr-labeled autologous EBV-B cells as
targets. At an effector-to-target ratio of 10 to 1, none of
the 28 H. pylori–specific clones from MALT lymphoma
was able to lyse target cells. In contrast, 27 of the 33 Th
clones from chronic gastritis lysed H. pylori antigen–
presenting autologous EBV-B cells (Figure 3A). The lack
of perforin-mediated cytotoxicity of the H. pylori–specific
clones from MALT lymphoma was confirmed in a
lectin-dependent cytolytic assay (Figure 3A). Among the
137 CD41 and 16 CD81 T-cell clones with undefined
antigen specificity, only 13% of CD41 and 44% of CD81
clones showed lectin-dependent cytotoxicity, whereas
88% of CD41 (P , 0.0001) and 95% of CD81 (P ,
0.0005) gastric clones derived from chronic gastritis were
cytolytic in the same assay.
To assess whether the reduced cytolytic activity of T
cells from patients with MALT lymphoma was peculiar to
their gastric infiltrates or a general T-cell defect, PPD-
specific T-cell clones derived from their peripheral blood
were compared for perforin-mediated cytotoxicity with
PPD-specific clones derived from the peripheral blood of
patients with chronic gastritis. At an effector-to-target
ratio of 10 to 1, PPD-specific clones from MALT
lymphoma and chronic gastritis were equally able to lyse
PPD-pulsed autologous EBV-B cells (70.5% 612% and
67.3% 617% mean 6 SD specific 51Cr-release, respec-
tively).
Deficiency of Fas-Fas Ligand-Mediated
Apoptotic Killing in Gastric T-Cell Clones
From MALT Lymphoma
Activated T cells can also kill their targets by
inducing apoptosis through Fas-Fas ligand interac-
tion.11–13,21 The ability of activated gastric T-cell clones
to induce 51Cr-release by Fas1 Jurkat cells undergoing
apoptosis was evaluated. Only 21% of H. pylori–specific
clones from MALT lymphoma induced apoptosis, whereas
88% of clones from chronic gastritis induced apoptosis
under the same conditions (P , 0.0001; Figure 4). The
role of Fas-Fas ligand interaction in this 51Cr-release was
confirmed by its inhibition by a blocking anti-Fas
antibody (Table 2). In the series of MALT lymphoma–
Figure 2. H. pylori antigen–stimulated T-cell clones derived from the
gastric mucosa of patients with MALT lymphoma provide autologous B
cells with boundless help for proliferation. Irradiated T-cell blasts of
each H. pylori–reactive clone derived from patients with gastric MALT
lymphoma (squares) or chronic gastritis (circles) were cocultured for 4
days with peripheral blood autologous B cells (3 3 104) at 0.2-, 1-, and
5-to-1 T-to-B-cell ratios in the presence of medium alone or H. pylori
antigen. Sixteen hours before harvesting, 0.5 µCi of [3H]thymidine
was added, and its uptake was measured and expressed as mitogenic
index. Results obtained with 2 series of 12 representative gastric
clones from patients with chronic gastritis or MALT lymphoma are
shown. Numbers and symbols allow the recognition of single T-cell
clones in subsequent figures.
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derived clones with undefined specificity, only 27% of
CD41 and 63% of CD81 clones induced apoptosis,
whereas 91% of CD41 (P , 0.0001) and 95% of CD81
clones (P , 0.01) from chronic gastritis induced apop-
totic death in Jurkat cells. However, no difference was
found in the proapoptotic activity of PPD-specific T-cell
clones from the peripheral blood of patients with MALT
lymphoma or chronic gastritis (51.3% 6 14% and
47.9% 6 12% specific 51Cr-release, respectively).
To assess whether the poor ability of T-cell clones
derived from MALT lymphoma to induce apoptosis in
Jurkat cells was simply related to a deficiency of Fas
ligand expression, polyclonal T-cell lines derived from
gastric biopsy specimens of the same patients with MALT
lymphoma and chronic gastritis were compared for Fas
ligand expression before and after stimulation with PMA
and ionomycin. In all of the unstimulated T-cell lines
derived from MALT lymphoma and chronic gastritis
biopsy specimens, the number of T-cell blasts stained by
the anti-Fas ligand antibody and the mean fluorescence
intensity recorded at flow cytometry did not differ from
those obtained with the isotype control (Figure 5). In
contrast, upon stimulation with PMA and ionomycin, all
of the gastric T-cell lines derived from either MALT
lymphoma or chronic gastritis showed almost equal Fas
ligand expression (Figure 5).
Discussion
In vivo–activated T cells in the lesional gastric
mucosa of 5 patients with H. pylori–associated low-grade
MALT lymphoma were expanded in vitro and efficiently
cloned to assess their specificity for H. pylori and functional
profile. This procedure has proved useful and accurate for
in vitro studies of tissue-infiltrating T cells in various
diseases.23,24 In the progeny of gastric T cells from either
MALT lymphoma or chronic gastritis, a noticeable pro-
portion of T-cell clones were reactive to H. pylori antigens.
As observed in other H. pylori–infected patients with
uncomplicated chronic gastritis25 or peptic ulcer,16 each
patient with MALT lymphoma contributed an almost
equal number of gastric T-cell clones, whose functional
features were consistently shared by each patient.
Figure 3. Failure of H. pylori–reactive T-cell clones derived from the
gastric mucosa of patients with MALT lymphoma to express (A)
antigen-induced per forin-mediated cytotoxicity against antigen-
presenting autologous EBV-B cells and (B) lectin-dependent cytotoxic-
ity to P815 target cells. Cytolytic activity of each H. pylori–reactive
gastric T-cell clone from patients with MALT lymphoma or chronic
gastritis was tested in triplicate at an effector-to-target ratio of 10 to 1
against 51Cr-labeled autologous EBV-B cells pulsed with H. pylori
antigens (A) and against 51Cr-labeled P815 murine mastocytoma cell
line in the presence of phytohemagglutinin (B). Percent of specific 51Cr
release was calculated as described in Materials and Methods. The
dotted lines indicate 5 SD above the mean spontaneous release of
target cells alone. Numbers and symbols allow the recognition of
single T-cell clones in previous and subsequent figures.
Figure 4. Reduced ability of H. pylori–reactive T-cell clones derived
from the gastric mucosa of patients with MALT lymphoma to induce Fas-Fas
ligand–mediated apoptosis and lysis in Jurkat cells. T-cell blasts of each
H. pylori–reactive gastric T-cell clone from patients with MALT lym-
phoma or chronic gastritis were tested in triplicate at an effector-to-
target ratio of 10 to 1 against 51Cr-labeled Jurkat cells in the absence
or presence of 10 ng/mL PMA and 1 mmol/L ionomycin. After 18 hours,
the percent of specific 51Cr release was calculated as described in
Materials and Methods. The dotted lines indicate 5 SD above the
mean spontaneous release of target cells alone. Numbers and
symbols allow the recognition of single T-cell clones in previous figures.
November 1999 B–CELL HELP BY T CELLS IN MALT LYMPHOMA 1109
Whether infection with more aggressive CagA1 H.
pylori strains is associated with MALT lymphoma is still
controversial.26,27 Present data suggest that CagA is not
the immunodominant target of gastric T cells, as in
chronic gastritis complicated by peptic ulcer.16 Rather, in
both MALT lymphoma and uncomplicated chronic gastri-
tis, urease seems to be a major antigen recognized by the
local T-cell response. On the other hand, most T-cell
clones from MALT lymphoma responded only to H. pylori
lysate, suggesting that some other still undefined anti-
gens of H. pylori may be involved.
In comparison with clones generated from chronic
gastritis, H. pylori–activated T-cell clones from MALT
lymphoma showed higher helper activity for B-cell
proliferation. This supports the concept that H. pylori–
specific T cells are in some way responsible for the
abnormal B-cell growth, which probably precedes and
favors the development of low-grade B-cell lymphoma at
gastric level in some H. pylori–infected patients. A
possible mechanism for enhanced B-cell proliferation
might be abnormal production of Th-derived cytokines
active on B-cell growth. MALT lymphoma–like lesions of
the gastric mucosa were found after long-term Helicobacter
felis infection in aged BALB/c mice, a strain genetically
prone to high production of Th2 cytokines and B-cell
response.28 Th2-skewed cytokine production in the local
T-cell response might account for enhanced B-cell prolif-
eration in MALT lymphoma. However, apart from a
lower proportion of Th1 and rare Th2 clones, most MALT
lymphoma T cells were Th0, as were most clones
obtained from uncomplicated chronic gastritis. Likewise,
the amounts of cytokines produced at single-cell level in
the 2 series of Th0 clones were comparable. Upon in vitro
stimulation with H. pylori, strong IFN-g response and
relatively small production of Th2 cytokines were ob-
served in tumor-infiltrating T cells from 2 patients with
MALT lymphoma.29 Taken together, these studies sug-
gest that both Th1-type (IFN-g and IL-2) and Th2-type
(IL-4, IL-10, and IL-13) cytokines, all sharing B-cell
growth factor activity,30 can be secreted by H. pylori–
stimulated MALT lymphoma T cells, suggesting that
mechanisms other than cytokines are involved in the H.
pylori–dependent enhanced T-cell help for B-cell prolifera-
tion. Another possibility is that enhanced B-cell growth
is related to defective T-cell regulation of B-cell response.
Depending on antigen challenge, expansion of T cells
occurs in the early phases of immune response. When
effector mechanisms and B-cell humoral response are
fully activated and pathogen clearance is possibly achieved,
a decrease in antigen-induced help for B-cell proliferation
is observed. In vitro, a decrease in B-cell help at high
T–B-cell ratios is peculiar to Th1 and most Th0 clones,
because of their concomitant expression of cytolytic
killing of antigen-presenting autologous B cells.20 This
cytolytic activity is perforin-mediated10,11 and usually
lacks in Th2 clones.20 Despite similar cytokine profiles, a
striking difference was found in the cytolytic potential of
T-cell clones derived from MALT lymphoma or chronic
gastritis. Whereas most chronic gastritis clones expressed
cytotoxicity, none of the H. pylori–specific clones (and
only a few other CD41 or CD81 clones) from MALT
lymphoma were cytolytic.
T–B-cell interaction is a multistep process resulting in
B-cell help and/or Fas-Fas ligand–mediated B-cell death
depending on the functional commitment of the Th cells
involved. Induction of B-cell apoptosis is a common
function of Th1 and Th0 but not Th2 cells.31 In the
present study, all Th1 and most Th0 clones from chronic
gastritis, either reactive or nonreactive to H. pylori,
induced Fas-Fas ligand–mediated apoptosis in target
cells. In contrast, in the series of gastric clones from
MALT lymphoma, only 21% of H. pylori–specific clones
and 27% of CD41 clones with undefined specificity
(mainly Th1 and a few Th0) were able to induce
apoptosis. The inhibitory effect of anti-Fas blocking
antibody on the proapoptotic activity of these few gastric
clones from MALT lymphoma allowed suspicion that the
failure in the induction of apoptosis shown by the
majority of MALT lymphoma–derived T-cell clones was
Table 2. Inhibition by Anti-Fas Monoclonal Antibody of
Apoptosis and Lysis Induced in Jurkat Cells by
H. pylori–Reactive T-Cell Clones Derived From
Gastric Mucosa of Patients With MALT Lymphoma
or Chronic Gastritis
Source of T-cell clones Anti-Fas added % Specific 51Cr releasea
MALT lymphoma
Clone 18 2 58.3
1 30.6
Clone 21 2 49.2
1 22.7
Clone 25 2 31.8
1 17.6
Chronic gastritis
Clone 6 2 74.7
1 30.8
Clone 26 2 56.5
1 33.6
Clone 33 2 40.1
1 21.8
None 2 10.7
1 14.4
aT-cell blasts of each clone were cocultured for 18 hours in triplicate at
a 10-to-1 ratio with 51Cr-labeled Jurkat cells pretreated for 30 minutes
with 5 µg/mL of the anti-Fas antagonistic M3 antibody or its isotype
control in the presence of PMA (10 ng/mL) and ionomycin (1 mmol/L).
Anti-Fas monoclonal antibody or its isotype control was also added
during the assay at 2 µg/mL final concentration. The results of 6
clones representative of 24 tested are reported.
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attributable simply to their inability to adequately
express membrane Fas ligand. However, compared with
those derived from chronic gastritis, gastric T-cell lines
derived from MALT lymphoma showed no substantial
difference in Fas ligand expression in terms of the
proportions of positive cells or of the mean fluorescence
intensity. Thus, unless most of the T cells infiltrating the
gastric MALT lymphoma express a Fas ligand molecule
that maintains a normal immunoreactivity but is actually
hampered in its function, the discrepancy between pheno-
typical and functional data remains unexplained.
In conclusion, gastric T cells from MALT lymphoma
show both defective perforin-mediated cytotoxicity and
poor ability to induce apoptosis, thus providing a
possible explanation for their enhanced helper activity on
B-cell proliferation. Both defects seem to be restricted to
MALT lymphoma–infiltrating T cells, because PPD-
specific T cells from peripheral blood of the same patients
expressed the same degree of either cytolytic potential or
proapoptotic activity as control clones derived from
patients with chronic gastritis. The reason gastric T cells
of MALT lymphoma, while delivering full help to B cells,
are apparently deficient in 2 mechanisms involved in the
concomitant control of B-cell growth remains unclear. It
has been shown that VacA toxin released by H. pylori
strains harboring a pathogenicity island32 inhibits anti-
gen processing in APCs but not the exocytosis of
perforin-containing granules of natural killer cells.33 It is
possible that, in some H. pylori–infected individuals,
other bacterial components affect the development or
expression of regulatory cytotoxic mechanisms on B-cell
proliferation by gastric T cells, allowing exhaustive and
unbalanced B-cell help and lymphomagenesis.
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